Eevia Health Oyj Past Earnings Performance
Past criteria checks 0/6
Eevia Health Oyj's earnings have been declining at an average annual rate of -3.2%, while the Pharmaceuticals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 16.3% per year.
Key information
-3.2%
Earnings growth rate
32.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 30.5% |
| Revenue growth rate | 16.3% |
| Return on equity | -6.7% |
| Net Margin | -5.6% |
| Next Earnings Update | 20 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Eevia Health Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 5 | 0 | 1 | 0 |
| 30 Sep 23 | 6 | -1 | 3 | 0 |
| 30 Jun 23 | 6 | -1 | 3 | 0 |
| 31 Mar 23 | 6 | -1 | 2 | 0 |
| 31 Dec 22 | 6 | -2 | 3 | 0 |
| 30 Sep 22 | 5 | -2 | 3 | 0 |
| 30 Jun 22 | 6 | -3 | 3 | 0 |
| 31 Mar 22 | 5 | -3 | 2 | 0 |
| 31 Dec 21 | 7 | -3 | 3 | 0 |
| 30 Sep 21 | 8 | -2 | 2 | 0 |
| 30 Jun 21 | 7 | -2 | 2 | 0 |
| 31 Mar 21 | 6 | -1 | 2 | 0 |
| 31 Dec 20 | 3 | -1 | 1 | 0 |
| 31 Dec 19 | 1 | 0 | 1 | 0 |
| 31 Dec 18 | 1 | -1 | 1 | 0 |
| 31 Dec 17 | 1 | -1 | 0 | 0 |
Quality Earnings: EEVIA is currently unprofitable.
Growing Profit Margin: EEVIA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EEVIA is unprofitable, and losses have increased over the past 5 years at a rate of 3.2% per year.
Accelerating Growth: Unable to compare EEVIA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EEVIA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (3%).
Return on Equity
High ROE: EEVIA has a negative Return on Equity (-6.75%), as it is currently unprofitable.